| |
|---|
AAAHC Institute for Quality Improvement, Performance Measurement Initiative, Colonoscopy Work Group (1) AAAHC Institute for Quality Improvement Performance Measurement Initiative - Intra-procedure colonoscopy complication rate: percentage of patients who developed one or more intra-procedure complications.
|
|
Agency for Healthcare Research and Quality (51) Agency for Healthcare Research and Quality (AHRQ) Quality Indicators - Abdominal aortic aneurysm (AAA) repair mortality: percentage in-hospital deaths per 1,000 discharges with AAA repair, ages 18 years and older.
- Accidental puncture or laceration: percentage of accidental punctures or lacerations during procedure per 1,000 discharges for patients ages 17 years and younger.
- Accidental puncture or laceration: percentage of accidental punctures or lacerations during procedure per 1,000 discharges for patients ages 18 years and older.
- Acute myocardial infarction (AMI) mortality: percentage in-hospital deaths per 1,000 discharges with AMI as principal diagnosis for patients ages 18 years and older.
- Acute stroke mortality: percentage in-hospital deaths per 1,000 discharges with acute stroke as principal diagnosis for patients ages 18 years and older.
- Asthma admission: percentage of admissions with a principal diagnosis of asthma per 100,000 population, ages 2 through 17 years.
- Bilateral cardiac catheterization: percentage of bilateral cardiac catheterization discharges per 1,000 heart catheterization discharges for coronary artery disease for patients 18 years and older.
- Congestive heart failure mortality: percentage in-hospital deaths per 1,000 discharges with heart failure as principal diagnosis for patients ages 18 years and older.
- Dehydration admission: percentage of admissions with a principal diagnosis of dehydration per 100,000 population, ages 18 years and older.
- Diabetes long term complications admission: percentage of admissions for a principal diagnosis of diabetes with long-term complications per 100,000 population, ages 18 years and older.
- Diabetes short term complications admission: percentage of admissions for a principal diagnosis of diabetes with short-term complications per 100,000 population, ages 18 years and older.
- Esophageal resection mortality: percentage in-hospital deaths per 1,000 discharges with esophageal resection for cancer, ages 18 years and older.
- Gastroenteritis admission: percentage of admissions with a principal diagnosis of gastroenteritis, or for a principal diagnosis of dehydration with a secondary diagnosis of gastroenteritis per 100,000 population, ages 3 months through 17 years.
- Hip fracture mortality: percentage in-hospital deaths per 1,000 discharges with hip fracture as principal diagnosis for patients ages 65 years and older.
- Iatrogenic pneumothorax: percentage of iatrogenic pneumothorax cases per 1,000 discharges for patients ages 17 years and younger.
- Lower-extremity amputation among patients with diabetes: percentage of admissions for any-listed diagnosis of diabetes and any-listed procedure of lower extremity amputation per 100,000 population, ages 18 years and older.
- Neonatal blood stream infection: percentage of discharges with healthcare-associated bloodstream infections per 1,000 discharges for newborns and outborns with birth weight of 500 grams or more but less than 1,500 grams; with gestational age between 24 and 30 weeks; or with birth weight of 1,500 grams or more and death, an operating room procedure, mechanical ventilation, or transferring from another hospital within two days of birth.
- Pancreatic resection mortality: percentage in-hospital deaths per 1,000 discharges with pancreatic resection for cancer, ages 18 years and older.
- Perforated appendix admission rate: percentage of admissions for any-listed diagnosis of perforations or abscesses of the appendix per 1,000 admissions with any listed appendicitis, ages 18 years and older.
- Pneumonia mortality: percentage in-hospital deaths per 1,000 discharges with pneumonia as principal diagnosis for patients ages 18 years and older.
- Pressure ulcer: percentage of stage III or IV pressure ulcers per 1,000 discharges for patients ages 17 years and younger.
- Uncontrolled diabetes admission: percentage of admissions for a principal diagnosis of diabetes without mention of short-term or long-term complications per 100,000 population, ages 18 years and older.
- Urinary tract infection admission: percentage of admissions with a principal diagnosis of urinary tract infection per 100,000 population, ages 18 years and older.
CAHPS American Indian Survey - Patients' experiences: patients' overall rating of clinic.
- Patients' experiences: patients' overall rating of provider.
- Patients' experiences: percentage of patients who reported how often office staff was courteous and helpful.
- Patients' experiences: percentage of patients who reported how often their provider communicated well.
- Patients' experiences: percentage of patients who reported how often their provider seemed informed and up-to-date about the care from specialists.
- Patients' experiences: percentage of patients who reported how often they were able to get care quickly.
- Patients' experiences: percentage of patients who reported how often they were able to get needed care.
- Patients' experiences: percentage of patients who reported whether their provider gave them guidance about their personal health.
- Patients' experiences: percentage of patients who reported whether their provider included them in decisions about their treatment or health care.
- Patients' experiences: percentage of patients who reported whether they perceived discrimination because of tribal affiliation.
CAHPS Child Hospital Survey - Hospital inpatients' experiences: parents' overall rating of hospital.
- Hospital inpatients' experiences: percentage of parents who reported how often doctors communicated well with their child.
- Hospital inpatients' experiences: percentage of parents who reported how often nurses communicated well with their child.
- Hospital inpatients' experiences: percentage of parents who reported how often providers kept them informed about their child's care.
- Hospital inpatients' experiences: percentage of parents who reported how often providers prevented mistakes and helped them to report concerns.
- Hospital inpatients' experiences: percentage of parents who reported how often the area around the room was quiet at night.
- Hospital inpatients' experiences: percentage of parents who reported how often the room and bathroom were kept clean.
- Hospital inpatients' experiences: percentage of parents who reported how often their child's doctors communicated well.
- Hospital inpatients' experiences: percentage of parents who reported how often their child's nurses communicated well.
- Hospital inpatients' experiences: percentage of parents who reported how often they got prompt help when they pressed the call button.
- Hospital inpatients' experiences: percentage of parents who reported how often they had privacy with providers when discussing their child's care.
- Hospital inpatients' experiences: percentage of parents who reported whether providers asked about their child's pain.
- Hospital inpatients' experiences: percentage of parents who reported whether providers communicated about their child's medicines.
- Hospital inpatients' experiences: percentage of parents who reported whether providers involved teens in their care.
- Hospital inpatients' experiences: percentage of parents who reported whether the provider prepared them and their child to leave the hospital.
- Hospital inpatients' experiences: percentage of parents who reported whether they were kept informed about their child's care in the emergency room.
- Hospital inpatients' experiences: percentage of parents who reported whether they would recommend this hospital to their family and friends.
- Hospital inpatients' experiences: percentage of parents who reported whether providers helped their child feel to comfortable.
|
|
Ambulatory Surgery Center (ASC) Quality Collaboration (9) Ambulatory Surgery Center (ASC) Quality Measures - Ambulatory surgery: percentage of Ambulatory Surgery Center (ASC) admissions experiencing a burn prior to discharge.
- Ambulatory surgery: percentage of Ambulatory Surgery Center (ASC) admissions experiencing a fall within the confines of the ASC.
- Ambulatory surgery: percentage of Ambulatory Surgery Center (ASC) admissions experiencing a wrong site, wrong side, wrong patient, wrong procedure, or wrong implant.
- Ambulatory surgery: percentage of Ambulatory Surgery Center (ASC) admissions requiring a hospital transfer or hospital admission upon discharge from the ASC.
- Ambulatory surgery: percentage of Ambulatory Surgery Center (ASC) admissions with an order for a prophylactic IV antibiotic for prevention of surgical site infection, who received the prophylactic antibiotic on time.
- Ambulatory surgery: percentage of Ambulatory Surgery Center (ASC) admissions with surgical site hair removal with a razor or clippers from the scrotal area, or with clippers or depilatory cream for all other surgical sites.
- Ambulatory surgery: percentage of cataract surgery patients who have an unplanned anterior vitrectomy.
- New Ambulatory surgery: percentage of ophthalmic anterior segment surgery patients diagnosed with toxic anterior segment syndrome (TASS) within 2 days of surgery.
- Ambulatory surgery: percentage of patients having surgical procedures under general or neuraxial anesthesia of 60 minutes or more in duration who are normothermic within 15 minutes of arrival in the post-anesthesia care unit (PACU).
|
|
American Academy of Neurology (24) Amyotrophic Lateral Sclerosis Quality Measurement Set - Amyotrophic lateral sclerosis (ALS): percentage of patients diagnosed with ALS and dysphagia, weight loss, or impaired nutrition who were offered at least once annually dietary or enteral nutrition support via percutaneous endoscopic gastrostomy or radiographic inserted gastrostomy.
- Amyotrophic lateral sclerosis (ALS): percentage of patients diagnosed with ALS for whom a multi-disciplinary care plan was developed, if not done previously, and the plan was updated at least once annually.
- Amyotrophic lateral sclerosis (ALS): percentage of patients diagnosed with ALS who are dysarthric who were offered a referral at least once annually to a speech language pathologist for an augmentative/alternative communication evaluation.
- Amyotrophic lateral sclerosis (ALS): percentage of patients diagnosed with ALS who are screened at least once annually for cognitive impairment and behavioral impairment.
- Amyotrophic lateral sclerosis (ALS): percentage of patients diagnosed with ALS who were offered at least once annually assistance in planning for end of life issues.
- Amyotrophic lateral sclerosis (ALS): percentage of patients diagnosed with ALS who were screened at least every 3 months for dysphagia, weight loss or impaired nutrition and the result(s) of the screening(s) was documented in the medical record.
- Amyotrophic lateral sclerosis (ALS): percentage of patients with a diagnosis of ALS who were queried about symptoms of respiratory insufficiency and referred for pulmonary function testing, maximum inspiratory pressure, sniff nasal pressure, or peak cough expiratory flow, at least every three months.
- Amyotrophic lateral sclerosis (ALS): percentage of patients with a diagnosis of ALS with whom the clinician discussed disease modifying pharmacotherapy to slow ALS disease progression at least once annually.
- Amyotrophic lateral sclerosis (ALS): percentage of visits for patients with a diagnosis of ALS with patient queried about falls within the past 12 months.
- Amyotrophic lateral sclerosis (ALS): percentage of visits for patients with a diagnosis of ALS with patients offered treatment for pseudobulbar affect, sialorrhea, and ALS related symptoms.
Distal Symmetric Polyneuropathy Quality Measurement Set - Distal symmetric polyneuropathy (DSP): percentage of patient visits for patient age 18 years and older with a diagnosis of distal symmetric polyneuropathy who was queried about pain and pain interference with function using a valid and reliable instrument.
- Distal symmetric polyneuropathy (DSP): percentage of patients age 18 years and older with a diagnosis of distal symmetric polyneuropathy (DSP) who had electrodiagnostic studies (EDX) conducted, documented and reviewed within 6 months of initial evaluation for DSP.
- Distal symmetric polyneuropathy (DSP): percentage of patients age 18 years and older with a diagnosis of distal symmetric polyneuropathy (DSP) who had screening tests for diabetes reviewed, requested or ordered when seen for an initial evaluation for DSP.
- Distal symmetric polyneuropathy (DSP): percentage of patients age 18 years and older with a diagnosis of distal symmetric polyneuropathy (DSP) who were screened with a validated screening instrument for unhealthy alcohol use when seen for an initial evaluation for DSP.
- Distal symmetric polyneuropathy (DSP): percentage of patients age 18 years and older with a diagnosis of distal symmetric polyneuropathy who were queried at least once annually about falls within the past 12 months and the response was documented.
- Distal symmetric polyneuropathy (DSP): percentage of patients age 18 years and older with a diagnosis of DSP who had their neuropathic symptoms and signs reviewed and documented at the initial evaluation for DSP.
Epilepsy Quality Measurement Set - Epilepsy: all female patients of childbearing potential (12 to 44 years old) diagnosed with epilepsy who were counseled or referred for counseling for how epilepsy and its treatment may affect contraception OR pregnancy at least once a year.
- Epilepsy: percentage of all patients with a diagnosis of epilepsy with active anti-seizure therapy side effects for whom an intervention was discussed.
- Epilepsy: percentage of all patients with a diagnosis of epilepsy, or their caregivers, who were provided with personalized safety issue and epilepsy education at least once annually.
- Epilepsy: percentage of all patients with a diagnosis of treatment resistant (intractable) epilepsy who were referred for consultation to a comprehensive epilepsy center for additional management of epilepsy.
- Epilepsy: percentage of all visits for patients with a diagnosis of epilepsy where the patient was screened for psychiatric or behavioral disorders
- Epilepsy: percentage of all visits for patients with a diagnosis of epilepsy where the seizure frequency of each seizure type was documented.
- Epilepsy: percentage of all visits for patients with a diagnosis of epilepsy with seizure type and epilepsy etiology or syndrome documented OR testing ordered to determine etiology of epilepsy, seizure type, or epilepsy syndrome.
- Epilepsy: percentage of patients with a diagnosis of epilepsy with seizure frequency greater than 0 for whom an intervention to reduce seizure frequency was offered or discussed with the patient or caregiver.
|
|
American Academy of Ophthalmology (5) Eye Care Quality Measures - Age-related macular degeneration (AMD): percentage of patients aged 50 years and older with a diagnosis of AMD or their caregiver(s) who were counseled within 12 months on the benefits and/or risks of the Age-Related Eye Disease Study (AREDS) formation for preventing progression of AMD.
- Age-related macular degeneration (AMD): percentage of patients aged 50 years and older with a diagnosis of AMD who had a dilated macular examination performed which included documentation of the presence or absence of macular thickening or hemorrhage, AND the level of macular degeneration severity during one or more office visits within 12 months.
- Cataracts: percentage of patients aged 18 years and older with a procedure of cataract surgery with IOL placement who received a comprehensive preoperative assessment of 1) dilated fundus exam; 2) axial length, corneal keratometry measurement, and method of IOL power calculation; and 3) functional or medical indication(s) for surgery prior to the cataract surgery with IOL placement within 12 months prior to cataract surgery.
- Primary open-angle glaucoma (POAG): percentage of patients aged 18 years and older with a diagnosis of POAG or their caregiver who were counseled within 12 months about 1) the potential impact of glaucoma on their visual functioning and quality of life, and 2) the importance of treatment adherence.
- Primary open-angle glaucoma (POAG): percentage of patients aged 18 years and older with a diagnosis of POAG whose glaucoma treatment has not failed (the most recent IOP was reduced by at least 15% from the pre-intervention level) OR if the most recent IOP was not reduced by at least 15% from the pre-intervention level, a plan of care was documented within 12 months.
|
|
American Academy of Orthopaedic Surgeons (1) Osteoarthritis Physician Performance Measurement Set - Osteoarthritis: percentage of patient visits for patients aged 21 and older with a diagnosis of osteoarthritis with assessment for function and pain.
|
|
American Academy of Sleep Medicine (4) Adult Obstructive Sleep Apnea - Adult obstructive sleep apnea: percentage of patients aged 18 years and older diagnosed with obstructive sleep apnea (OSA) that were prescribed an evidence-based therapy after initial diagnosis.
- Adult obstructive sleep apnea: percentage of patients aged 18 years and older with a diagnosis of obstructive sleep apnea (OSA) that had an apnea hypopnea index (AHI) or respiratory disturbance index (RDI), or respiratory event index (REI) documented or measured within 2 months of initial evaluation for suspected OSA.
- Adult obstructive sleep apnea: percentage of patients aged 18 years and older with a diagnosis of obstructive sleep apnea (OSA) that have documentation of assessment of OSA symptoms at initial evaluation, including, but no limited to, the presence of snoring and daytime sleepiness.
- Adult obstructive sleep apnea: percentage of patients aged 18 years and older with obstructive sleep apnea (OSA) that were prescribed an evidence-based therapy who had documentation that adherence to therapy was assessed at least annually.
|
|
American College of Radiology (45) Diagnostic Imaging Performance Measurement Set - Diagnostic imaging: percentage of final reports for abdominal imaging studies for asymptomatic patients aged 18 years and older with one or more of the following noted incidentally with follow-up imaging recommended: liver lesion less than or equal to 0.5 cm, cystic kidney lesion less than 1.0 cm or adrenal lesion less than or equal to 1.0 cm.
- Diagnostic imaging: percentage of final reports for carotid imaging studies (neck magnetic resonance angiography [MRA], neck computerized tomographic angiography [CTA], neck duplex ultrasound, carotid angiogram) performed that include direct or indirect reference to measurements of distal internal carotid diameter as the denominator for stenosis measurement.
- Diagnostic imaging: percentage of final reports for computed tomography (CT) or magnetic resonance imaging (MRI) studies of the chest or neck or ultrasound of the neck for patients aged 18 years and older with no known thyroid disease with a thyroid nodule less than 1.0 cm noted incidentally with follow-up imaging recommended.
- Diagnostic imaging: percentage of final reports for patients aged 18 years and older undergoing computed tomography (CT) with documentation that one or more of the specified dose optimization techniques were used.
- Diagnostic imaging: percentage of final reports for patients aged 18 years and older who had a previously documented iodinated contrast reaction who undergo any imaging examination using intravenous iodinated contrast that include documentation that the patients were pre-medicated with corticosteroids with or without H1 antihistamines.
- Diagnostic imaging: percentage of final reports for patients aged 18 years and older who received intravenous iodinated contrast for a computed tomography (CT) examination who had an extravasation of contrast.
- Diagnostic imaging: percentage of final reports for procedures using fluoroscopy that include radiation exposure indices, or exposure time and number of fluorographic images (if radiation exposure indices are not available).
- Diagnostic imaging: percentage of final reports for screening mammograms that are classified "probably benign."
- Diagnostic imaging: percentage of final reports for ultrasound studies of the pelvis for pre-menopausal women aged 18 and older with no known ovarian disease with a simple ovarian cyst less than 5.0 cm noted incidentally with follow-up imaging recommended.
- Diagnostic imaging: percentage of imaging studies for patients aged 18 years and older with knee pain who undergo knee magnetic resonance imaging (MRI) or magnetic resonance arthrography (MRA) who are known to have had knee radiographs performed within the preceding three months based on information from the radiology information system (RIS), patient-provided radiological history, or other health-care source.
- Diagnostic imaging: percentage of imaging studies for patients aged 18 years and older with shoulder pain undergoing shoulder magnetic resonance imaging (MRI), magnetic resonance arthrography (MRA), or a shoulder ultrasound who are known to have had shoulder radiographs performed within the preceding 3 months based on information from the radiology information system (RIS), patient-provided radiological history, or other health-care source
- Diagnostic imaging: percentage of patients aged 14 years and younger with clinically suspected appendicitis who undergo computed tomography (CT), magnetic resonance imaging (MRI), or ultrasound of the abdomen or pelvis for whom ultrasound was used as the initial imaging evaluation of the appendix.
- Diagnostic imaging: percentage of patients undergoing a screening mammogram whose information is entered into a reminder system with a target due date for the next mammogram.
National Radiology Data Registry Measurement Set - Diagnostic imaging: fraction of all screening mammograms that are interpreted as positive (abnormal) and have a tissue diagnosis of cancer within 12 months.
- Diagnostic imaging: fraction of all screening mammograms that are interpreted as positive (abnormal) and have a tissue diagnosis of invasive cancer within 12 months.
- Diagnostic imaging: mean CT report turnaround time (RTAT).
- Diagnostic imaging: mean MRI report turnaround time (RTAT).
- Diagnostic imaging: mean PET report turnaround time (RTAT).
- Diagnostic imaging: mean radiography report turnaround time (RTAT).
- Diagnostic imaging: mean ultrasound report turnaround time (RTAT).
- Diagnostic imaging: median Dose Length Product (DLP) for CT abdomen-pelvis with contrast (single phase scan).
- Diagnostic imaging: median Dose Length Product (DLP) for CT chest without contrast (single phase scan).
- Diagnostic imaging: median Dose Length Product (DLP) for CT head-brain without contrast (single phase scans).
- Diagnostic imaging: median Size Specific Dose Estimate (SSDE) for abdomen-pelvis CT with contrast (single phase scans).
- Diagnostic imaging: median Size Specific Dose Estimate (SSDE) for chest CT without contrast (single phase scans).
- Diagnostic imaging: number of CT exams performed at the facility that were submitted to the Dose Index Registry.
- Diagnostic imaging: percentage of all computed tomography colonography (CTC) exams, either screening or diagnostic, with a clinically significant extracolonic finding, not otherwise known based on the history provided or based on a prior imaging procedure at the institution.
- Diagnostic imaging: percentage of cancers detected at screening mammography that are invasive carcinoma less than or equal to 10 mm or ductal carcinoma in situ (DCIS).
- Diagnostic imaging: percentage of CT exams with contrast performed that resulted in extravasation.
- Diagnostic imaging: percentage of exams with confirming colonoscopies for a greater than or equal to 10mm polyp detected by CT colonography (CTC) (True Positive Rate).
- Diagnostic imaging: percentage of invasive cancers detected at screening mammography that are node negative.
- Diagnostic imaging: percentage of screening lung cancer exams interpreted as positive (Lung-RADS Category 3 or 4).
- Diagnostic imaging: percentage of screening mammograms interpreted as positive (abnormal).
- Diagnostic imaging: percentage of screening mammograms where biopsy was recommended that have a tissue diagnosis of cancer within 12 months.
- Diagnostic imaging: percentage of screenings for lung cancer with abnormal interpretation (Lung-RADS 3 or 4) that result in a tissue diagnosis of cancer within 12 months.
- Diagnostic imaging: percentage of screenings of lung cancer that were interpreted as positive (Lung-RADS category 3 or 4) and result in a tissue diagnosis of cancer within 12 months.
- Diagnostic imaging: percentage of surgical patients aged 18 years and older undergoing procedures with the indications for prophylactic parenteral antibiotics, who have an order for prophylactic parenteral antibiotic to be given within 1 hour (2 if fluoroquinolone or vancomy).
Optimizing Patient Exposure to Ionizing Radiation Performance Measurement Set - Optimizing patient exposure to ionizing radiation: percentage of CT and cardiac nuclear medicine (myocardial perfusion studies) imaging reports for all patients, regardless of age, that document a count of known previous CT (any type of CT) and cardiac nuclear medicine (myocardial perfusion) studies that the patient has received in the 12-month period prior to the current study.
- Optimizing patient exposure to ionizing radiation: percentage of CT imaging reports for all patients, regardless of age, with the imaging study named according to a standardized nomenclature and the standardized nomenclature is used in institution’s computer systems.
- Optimizing patient exposure to ionizing radiation: percentage of final reports for CT imaging studies of the thorax for patients aged 18 years and older with documented follow-up recommendations for incidentally detected pulmonary nodules based at a minimum on nodule size and patient risk factors.
- Optimizing patient exposure to ionizing radiation: percentage of final reports for CT studies performed for all patients, regardless of age, which document that Digital Imaging and Communications in Medicine (DICOM) format image data are available to non-affiliated external healthcare facilities or entities on a secure, media free, reciprocally searchable basis with patient authorization for at least a 12-month period after the study.
- Optimizing patient exposure to ionizing radiation: percentage of final reports of CT studies performed for all patients, regardless of age, which document that a search for Digital Imaging and Communications in Medicine (DICOM) format images was conducted for prior patient CT imaging studies completed at non-affiliated external entities within the past 12-months and are available through a secure, authorized, media-free, shared archive prior to an imaging study being performed.
- Optimizing patient exposure to ionizing radiation: percentage of pediatric CT imaging studies for patients aged 17 years and younger performed with equipment that has complied with a CT equipment evaluation protocol at least once within the 12-month period prior to the exam.
- Optimizing patient exposure to ionizing radiation: percentage of pediatric CT imaging studies for patients aged 17 years and younger performed with individualized equipment evaluation protocols that comply with a widely used guideline.
- Optimizing patient exposure to ionizing radiation: percentage of total CT studies performed for all patients, regardless of age, that are reported to a radiation dose index registry and that include at a minimum selected data elements.
|
|
American Psychiatric Association (6) Adult Major Depressive Disorder Performance Measurement Set - Major depressive disorder (MDD): percentage of medical records of patients aged 18 years and older with a diagnosis of MDD and a specific diagnosed comorbid condition (diabetes, coronary artery disease, ischemic stroke, intracranial hemorrhage, chronic kidney disease [stages 4 or 5], ESRD or congestive heart failure) being treated by another clinician with communication to the clinician treating the comorbid condition.
- Major depressive disorder (MDD): percentage of patients aged 18 years and older with a diagnosis of MDD who have a depression severity classification and who receive, at a minimum, treatment appropriate to their depression severity classification at the most recent visit during the measurement period.
- Major depressive disorder (MDD): percentage of patients aged 18 years and older with a diagnosis of MDD who received patient education at least once during the measurement period, regarding the minimum specified criteria.
- Major depressive disorder (MDD): percentage of patients aged 18 years and older with a new diagnosis or recurrent episode of MDD with documentation of the patient's response to treatment three times in the first 90 days following diagnosis, and, if patient has not improved, documentation of treatment plan review or alteration.
- Major depressive disorder (MDD): percentage of patients aged 18 years and older with a new diagnosis or recurrent episode of MDD with three follow-up visits in the first 90 days following diagnosis of a new or recurrent episode of MDD.
- Major depressive disorder (MDD): percentage of patients aged 18 years and older with a new diagnosis or recurrent episode of MDD, with evidence that they met the DSM-IV-TR criteria for MDD AND for whom there is an assessment of depression severity during the visit in which a new diagnosis or recurrent episode was identified.
|
|
American Society of Hematology (15) Hematology Physician Performance Measurement Set - Hematology: percentage of patients aged 18 years and older with a diagnosis of multiple myeloma, not in remission, who were prescribed or received intravenous bisphosphonate therapy within the 12 month reporting period.
- Hematology: percentage of patients aged 18 years and older, seen within a 12 month reporting period, with a diagnosis of chronic lymphocytic leukemia (CLL) made at any time during or prior to the reporting period who had baseline flow cytometry studies performed and documented in the chart.
Myelodysplastic Syndromes - Myelodysplastic syndromes (MDS): percentage of higher-risk MDS patients receiving azacitidine or decitabine.
- Myelodysplastic syndromes (MDS): percentage of MDS patients presenting with anemia who had a serum erythropoietin level less than or equal to 500 mU/ml prior to receiving erythropoietin/darbepoetin therapy.
- Myelodysplastic syndromes (MDS): percentage of MDS patients presenting with anemia who had evidence of adequate iron stores within 60 days prior to receiving erythropoietin/darbepoetin therapy.
- Myelodysplastic syndromes (MDS): percentage of MDS patients who are candidates for allogeneic stem cell transplant receiving irradiated transfusion products.
- Myelodysplastic syndromes (MDS): percentage of MDS patients who had an established pathologic classification/risk prognostication system to help plan therapeutic options.
- Myelodysplastic syndromes (MDS): percentage of MDS patients whose baseline diagnostic evaluation includes cytogenetic testing on bone marrow by standard karyotyping methods.
- Myelodysplastic syndromes (MDS): percentage of patients with a diagnosis of MDS whose eligibility for a clinical trial was checked at least once a year.
Non-Hodgkin Lymphoma Measure Set - Non-Hodgkin lymphoma: percent of lymphoma patients advised to receive immunization/vaccination aligned with CDC recommendations.
- Non-Hodgkin lymphoma: percent of lymphoma patients assigned a specific stage using Ann Arbor system including presence/absence of B symptoms AND having bone marrow biopsy or documentation why bone marrow biopsy was unnecessary or contraindicated.
- Non-Hodgkin lymphoma: percent of lymphoma patients of childbearing age who received treatment for lymphoma and who were offered fertility counseling prior to starting treatment OR documentation in the medical record why such counseling was unnecessary.
- Non-Hodgkin lymphoma: percent of lymphoma patients treated with anti-CD20 monoclonal antibody-containing regimens and tested for hepatitis B prior to medication administration.
- Non-Hodgkin lymphoma: percent of lymphoma patients who are 65 years old or older and receiving CHOP +/-R, prescribed prophylactic granulocyte colony-stimulating factor (G-CSF).
- Non-Hodgkin lymphoma: percent of patients with lymphoma whose initial lymphoma diagnosis was established by one of the following: incisional or excisional biopsy AND immunohistochemical characterization, OR core needle biopsy AND appropriate ancillary techniques employed.
|
|
American Thoracic Society (2) Chronic Obstructive Pulmonary Disease (COPD) Measures - Chronic obstructive pulmonary disease (COPD): percentage of patients aged 18 years and older with a diagnosis of COPD and who have an FEV1/FVC less than 60% and have symptoms who were prescribed an inhaled bronchodilator.
- Chronic obstructive pulmonary disease (COPD): percentage of patients aged 18 years and older with a diagnosis of COPD who had spirometry results documented.
|
|
|
No hay comentarios:
Publicar un comentario